🔎 Trials Near Me

Akèy › Kansè fwa › Texas › Dallas

Etid klinik pou Kansè fwa nan Dallas, TX

10 etid pou Kansè fwa ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

DESTINY-PANTUMOUR04

Ap rekriteEtid obsèvasyon
  • Research Site, Dallas
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000

National Liver Cancer Screening Trial

Ap rekriteFaz 4
  • UT Southwestern Medical Center and Parkland Hospital, Dallas
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06084234

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

Ap rekriteFaz 1/2
  • University of Texas Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT04864054

A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

Ap rekriteFaz 1
  • NEXT Dallas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07337525

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

Ap rekriteFaz 1
  • Clinical Trial Site, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT06600321

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Ap rekrite
  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Jun 17, 2026 · NCT05486572

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • NEXT Dallas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Jan 21, 2026 · NCT07317505

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Dallas
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

EGCG for Hepatocellular Carcinoma Chemoprevention

Ap rekriteFaz 2
  • UT Southwestern, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 5, 2025 · NCT06015022

Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

Ap rekriteFaz 3
  • Site 881, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Apr 29, 2025 · NCT05201404

Etid Kansè fwa nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.